Drug Information

Drug General Information
Drug ID
D03FJK
Former ID
DNC005065
Drug Name
8-(1,3,3-Trimethyl-butoxy)-quinolin-2-ylamine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527195]
Formula
C16H22N2O
Canonical SMILES
CC(CC(C)(C)C)OC1=CC=CC2=C1N=C(C=C2)N
InChI
1S/C16H22N2O/c1-11(10-16(2,3)4)19-13-7-5-6-12-8-9-14(17)18-15(12)13/h5-9,11H,10H2,1-4H3,(H2,17,18)
InChIKey
ZDVPLVAZUCNXKZ-UHFFFAOYSA-N
PubChem Compound ID
10083869
Target and Pathway
Target(s) Melanin-concentrating hormone receptor 1 Target Info Inhibitor [527195]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Peptide ligand-binding receptors
G alpha (q) signalling events
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Gastrin-CREB signalling pathway via PKC and MAPK
GPCR ligand binding
GPCR downstream signaling
References
Ref 527195Bioorg Med Chem Lett. 2004 Oct 4;14(19):4879-82.Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 2.
Ref 527195Bioorg Med Chem Lett. 2004 Oct 4;14(19):4879-82.Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 2.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.